India's Orchid Establishes Japanese Subsidiary
This article was originally published in PharmAsia News
Executive Summary
Indian pharmaceutical company Orchid Chemicals and Pharmaceuticals set up a Japanese subsidiary, Orchid Pharma Japan, the company announced April 10. Orchid Managing Director C.B. Rao commented the Tokyo-based branch will tap the rapidly growing Japanese generics market, and plans to launch five to ten drugs and reach ¥10 billion in sales in five years. Orchid Pharma Japan President Kunihiko Iwate said the short term goal for the company is to strengthen sales in the Japanese generics market. (Click here for more - Japanese language